{"title":"FDA发布阿片类药物研究器械指南草案","authors":"Jay Geller","doi":"10.1097/jce.0000000000000618","DOIUrl":null,"url":null,"abstract":"Corresponding author: Jay Geller, JD, MBA, 121000 Wilshire Blvd, Ste 1250, Los Angeles, CA 90025 ([email protected]). The author declares no conflicts of interest.","PeriodicalId":77198,"journal":{"name":"Journal of clinical engineering","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FDA Releases Draft Guidance on Opioid Study Devices\",\"authors\":\"Jay Geller\",\"doi\":\"10.1097/jce.0000000000000618\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Corresponding author: Jay Geller, JD, MBA, 121000 Wilshire Blvd, Ste 1250, Los Angeles, CA 90025 ([email protected]). The author declares no conflicts of interest.\",\"PeriodicalId\":77198,\"journal\":{\"name\":\"Journal of clinical engineering\",\"volume\":\"61 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical engineering\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/jce.0000000000000618\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/jce.0000000000000618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
通讯作者:Jay Geller，法学博士，工商管理硕士，地址:121000 Wilshire Blvd, st 1250, Los Angeles, CA 90025 ([email protected])作者声明无利益冲突。
FDA Releases Draft Guidance on Opioid Study Devices
Corresponding author: Jay Geller, JD, MBA, 121000 Wilshire Blvd, Ste 1250, Los Angeles, CA 90025 ([email protected]). The author declares no conflicts of interest.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
